197 related articles for article (PubMed ID: 38658748)
1. PGE
Lacher SB; Dörr J; de Almeida GP; Hönninger J; Bayerl F; Hirschberger A; Pedde AM; Meiser P; Ramsauer L; Rudolph TJ; Spranger N; Morotti M; Grimm AJ; Jarosch S; Oner A; Gregor L; Lesch S; Michaelides S; Fertig L; Briukhovetska D; Majed L; Stock S; Busch DH; Buchholz VR; Knolle PA; Zehn D; Dangaj Laniti D; Kobold S; Böttcher JP
Nature; 2024 May; 629(8011):417-425. PubMed ID: 38658748
[TBL] [Abstract][Full Text] [Related]
2. PGE
Morotti M; Grimm AJ; Hope HC; Arnaud M; Desbuisson M; Rayroux N; Barras D; Masid M; Murgues B; Chap BS; Ongaro M; Rota IA; Ronet C; Minasyan A; Chiffelle J; Lacher SB; Bobisse S; Murgues C; Ghisoni E; Ouchen K; Bou Mjahed R; Benedetti F; Abdellaoui N; Turrini R; Gannon PO; Zaman K; Mathevet P; Lelievre L; Crespo I; Conrad M; Verdeil G; Kandalaft LE; Dagher J; Corria-Osorio J; Doucey MA; Ho PC; Harari A; Vannini N; Böttcher JP; Dangaj Laniti D; Coukos G
Nature; 2024 May; 629(8011):426-434. PubMed ID: 38658764
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral Tcf1
Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
[TBL] [Abstract][Full Text] [Related]
4. T cell-intrinsic prostaglandin E
Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E₂ down-regulates the expression of CD25 on bovine T cells, and this effect is mediated through the EP4 receptor.
Maślanka T; Spodniewska A; Barski D; Jasiecka A; Zuśka-Prot M; Ziółkowski H; Markiewicz W; Jaroszewski JJ
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):192-200. PubMed ID: 25001909
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E
Goepp M; Crittenden S; Zhou Y; Rossi AG; Narumiya S; Yao C
Immunology; 2021 Dec; 164(4):777-791. PubMed ID: 34529833
[TBL] [Abstract][Full Text] [Related]
7. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
[TBL] [Abstract][Full Text] [Related]
8. Metabolic regulation by prostaglandin E
Robb CT; Zhou Y; Felton JM; Zhang B; Goepp M; Jheeta P; Smyth DJ; Duffin R; Vermeren S; Breyer RM; Narumiya S; McSorley HJ; Maizels RM; Schwarze JKJ; Rossi AG; Yao C
Allergy; 2023 Mar; 78(3):714-730. PubMed ID: 36181709
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action.
Take Y; Koizumi S; Nagahisa A
Front Immunol; 2020; 11():324. PubMed ID: 32210957
[TBL] [Abstract][Full Text] [Related]
10. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.
Jansen CS; Prokhnevska N; Master VA; Sanda MG; Carlisle JW; Bilen MA; Cardenas M; Wilkinson S; Lake R; Sowalsky AG; Valanparambil RM; Hudson WH; McGuire D; Melnick K; Khan AI; Kim K; Chang YM; Kim A; Filson CP; Alemozaffar M; Osunkoya AO; Mullane P; Ellis C; Akondy R; Im SJ; Kamphorst AO; Reyes A; Liu Y; Kissick H
Nature; 2019 Dec; 576(7787):465-470. PubMed ID: 31827286
[TBL] [Abstract][Full Text] [Related]
11. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy.
Zhou T; Damsky W; Weizman OE; McGeary MK; Hartmann KP; Rosen CE; Fischer S; Jackson R; Flavell RA; Wang J; Sanmamed MF; Bosenberg MW; Ring AM
Nature; 2020 Jul; 583(7817):609-614. PubMed ID: 32581358
[TBL] [Abstract][Full Text] [Related]
12. Efficient T-cell priming and activation requires signaling through prostaglandin E2 (EP) receptors.
Sreeramkumar V; Hons M; Punzón C; Stein JV; Sancho D; Fresno M; Cuesta N
Immunol Cell Biol; 2016 Jan; 94(1):39-51. PubMed ID: 26051593
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
[TBL] [Abstract][Full Text] [Related]
14. Functional HPV-specific PD-1
Eberhardt CS; Kissick HT; Patel MR; Cardenas MA; Prokhnevska N; Obeng RC; Nasti TH; Griffith CC; Im SJ; Wang X; Shin DM; Carrington M; Chen ZG; Sidney J; Sette A; Saba NF; Wieland A; Ahmed R
Nature; 2021 Sep; 597(7875):279-284. PubMed ID: 34471285
[TBL] [Abstract][Full Text] [Related]
15. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
[TBL] [Abstract][Full Text] [Related]
17. Endogenous prostaglandin E
Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
[TBL] [Abstract][Full Text] [Related]
19. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.
Akbari B; Soltantoyeh T; Shahosseini Z; Jadidi-Niaragh F; Hadjati J; Brown CE; Mirzaei HR
Front Immunol; 2023; 14():1209572. PubMed ID: 37457723
[TBL] [Abstract][Full Text] [Related]
20. PGE2-EP4 signaling steers cDC2 maturation toward the induction of suppressive T-cell responses.
Cuenca-Escalona J; Flórez-Grau G; van den Dries K; Cambi A; de Vries IJM
Eur J Immunol; 2024 Mar; 54(3):e2350770. PubMed ID: 38088451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]